Amgen's Dividends per Share for the
three
months ended in Dec. 2023 was €1.95.
The historical rank and industry rank for Amgen's 3-Year Dividend Growth Rate or its related term are showing as below:
FRA:AMG'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 10 Med: 15.95 Max: 63.3
Current: 10
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Amgen was 63.30% per year. The lowest was 10.00% per year. And the median was 15.95% per year.
FRA:AMG's 3-Year Dividend Growth Rate is ranked better than 51.87% of 320
companies
in the Drug Manufacturers industry
Industry Median: 9.1
vs FRA:AMG: 10.00
During the past 12 months, Amgen's average Dividends Per Share Growth Rate was 9.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 10.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 15.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Amgen's 3-Year Dividend Growth Rate
For the Drug Manufacturers - General subindustry, Amgen's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amgen's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amgen's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Amgen's 3-Year Dividend Growth Rate falls into.
Amgen 3-Year Dividend Growth Rate Calculation
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Amgen was 1.71. The lowest was 0.35. And the median was 0.45.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Amgen Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 2.250
2024-02-15
2024-02-16
2024-03-07
Cash Dividend
quarterly
USD:EUR 0.927000
USD 2.130
2023-11-16
2023-11-17
2023-12-08
Cash Dividend
quarterly
USD:EUR 0.924000
USD 2.130
2023-08-17
2023-08-18
2023-09-08
Cash Dividend
quarterly
USD:EUR 0.917000
USD 2.130
2023-05-17
2023-05-18
2023-06-08
Cash Dividend
quarterly
USD:EUR 0.920000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Amgen's Dividend Yield (%) for Today is calculated as
Current Share Price is €256.85.
Amgen's Dividends per Share for the trailing twelve months (TTM) ended in Today is €7.96668.
During the past 13 years, the highest Dividend Yield of Amgen was 3.72%. The lowest was 1.35%. And the median was 2.57%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:AMG has been successfully added to your